BACKGROUND: Although both obesity and the metabolic syndrome (MetS) are known risk factors for decline in physical function, the joint association of obesity and metabolic alterations with risk of incident mobility limitation is unknown. METHODS: Data are from 2,984 women and men aged 70-79 years participating in the Health, Aging, and Body Composition Study without mobility limitation at baseline. Obesity was defined as body mass index greater than or equal to 30 kg/m(2) and the MetS as meeting greater than or equal to 3 of the ATP III criteria. Mobility limitation was defined as any difficulty walking one-quarter mile or climbing 10 steps during two consecutive semiannual assessments for more than 6.5 years. RESULTS: Incidence of mobility limitation was 55% in women and 44% in men. In women, adjusted risk of developing mobility limitation was progressively greater in nonobese participants with the MetS (hazard ratio [HR] = 1.49, 95% confidence interval [CI] = 1.24-1.80), obese participants without the MetS (HR = 1.95, 95% CI = 1.51-2.53), and obese participants with the MetS (HR = 2.16, 95% CI = 1.78-2.63) relative to the nonobese without the MetS. In men, the corresponding adjusted HRs (95% CI) were 1.07 (0.87-1.32), 1.64 (1.19-2.25), and 1.41 (1.12-1.78). Elevated inflammatory markers partly explained the association between obesity, the MetS, and mobility limitation, particularly in nonobese and obese participants with the MetS. CONCLUSIONS: Obesity itself, independent of its metabolic consequences, is a risk factor for mobility limitation among obese older adults. In addition, having the MetS increases the risk of functional decline in older nonobese women but not in men.
BACKGROUND: Although both obesity and the metabolic syndrome (MetS) are known risk factors for decline in physical function, the joint association of obesity and metabolic alterations with risk of incident mobility limitation is unknown. METHODS: Data are from 2,984 women and men aged 70-79 years participating in the Health, Aging, and Body Composition Study without mobility limitation at baseline. Obesity was defined as body mass index greater than or equal to 30 kg/m(2) and the MetS as meeting greater than or equal to 3 of the ATP III criteria. Mobility limitation was defined as any difficulty walking one-quarter mile or climbing 10 steps during two consecutive semiannual assessments for more than 6.5 years. RESULTS: Incidence of mobility limitation was 55% in women and 44% in men. In women, adjusted risk of developing mobility limitation was progressively greater in nonobese participants with the MetS (hazard ratio [HR] = 1.49, 95% confidence interval [CI] = 1.24-1.80), obeseparticipants without the MetS (HR = 1.95, 95% CI = 1.51-2.53), and obeseparticipants with the MetS (HR = 2.16, 95% CI = 1.78-2.63) relative to the nonobese without the MetS. In men, the corresponding adjusted HRs (95% CI) were 1.07 (0.87-1.32), 1.64 (1.19-2.25), and 1.41 (1.12-1.78). Elevated inflammatory markers partly explained the association between obesity, the MetS, and mobility limitation, particularly in nonobese and obeseparticipants with the MetS. CONCLUSIONS:Obesity itself, independent of its metabolic consequences, is a risk factor for mobility limitation among obese older adults. In addition, having the MetS increases the risk of functional decline in older nonobese women but not in men.
Authors: Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers Journal: Arch Intern Med Date: 2008-08-11
Authors: Tongjian You; Barbara J Nicklas; Jingzhong Ding; Brenda W J H Penninx; Bret H Goodpaster; Douglas C Bauer; Frances A Tylavsky; Tamara B Harris; Stephen B Kritchevsky Journal: J Gerontol A Biol Sci Med Sci Date: 2008-04 Impact factor: 6.053
Authors: Antony D Karelis; David H St-Pierre; Florence Conus; Remi Rabasa-Lhoret; Eric T Poehlman Journal: J Clin Endocrinol Metab Date: 2004-06 Impact factor: 5.958
Authors: Brenda W J H Penninx; Barbara J Nicklas; Anne B Newman; Tamara B Harris; Bret H Goodpaster; Suzanne Satterfield; Nathalie de Rekeneire; Kristine Yaffe; Marco Pahor; Stephen B Kritchevsky Journal: J Gerontol A Biol Sci Med Sci Date: 2009-01-20 Impact factor: 6.053
Authors: Stefano Volpato; Luigi Ferrucci; Caroline Blaum; Glenn Ostir; Anne Cappola; Linda P Fried; Renato Fellin; Jack M Guralnik Journal: Diabetes Care Date: 2003-01 Impact factor: 19.112
Authors: Luigi Ferrucci; Stephanie A Studenski; Dawn E Alley; Mario Barbagallo; Tamara B Harris Journal: J Gerontol A Biol Sci Med Sci Date: 2009-11-17 Impact factor: 6.053
Authors: Sari Stenholm; Annemarie Koster; Dawn E Alley; Marjolein Visser; Marcello Maggio; Tamara B Harris; Josephine M Egan; Stefania Bandinelli; Jack M Guralnik; Luigi Ferrucci Journal: Clin Endocrinol (Oxf) Date: 2010-07 Impact factor: 3.478
Authors: Dawn E Alley; Gregory E Hicks; Michelle Shardell; William Hawkes; Ram Miller; Rebecca L Craik; Kathleen K Mangione; Denise Orwig; Marc Hochberg; Barbara Resnick; Jay Magaziner Journal: J Am Geriatr Soc Date: 2011-08-24 Impact factor: 5.562
Authors: Susan A Everson-Rose; Misti Paudel; Brent C Taylor; Tien Dam; Peggy Mannen Cawthon; Erin Leblanc; Elsa S Strotmeyer; Jane A Cauley; Marcia L Stefanick; Elizabeth Barrett-Connor; Kristine E Ensrud Journal: J Am Geriatr Soc Date: 2011-08-01 Impact factor: 5.562
Authors: P Su; H Ding; W Zhang; G Duan; Y Yang; J Long; L Du; C Xie; C Jin; C Hu; Z Sun; Z Duan; L Gong; W Tian Journal: J Nutr Health Aging Date: 2017 Impact factor: 4.075
Authors: Anda Botoseneanu; Haiying Chen; Walter T Ambrosius; Heather G Allore; Stephen Anton; Sara C Folta; Abby C King; Barbara J Nicklas; Bonnie J Spring; Elsa S Strotmeyer; Thomas M Gill Journal: J Am Geriatr Soc Date: 2017-03-28 Impact factor: 5.562
Authors: Lyndon J Joseph; Ronald L Prigeon; Jacob B Blumenthal; Alice S Ryan; Andrew P Goldberg Journal: J Gerontol A Biol Sci Med Sci Date: 2011-06-08 Impact factor: 6.053
Authors: Elizabeth M Venditti; Marsha D Marcus; Rachel G Miller; Vincent C Arena; Susan L Greenspan; Bonny Rockette-Wagner Journal: J Gerontol A Biol Sci Med Sci Date: 2021-01-18 Impact factor: 6.053
Authors: M Lechleitner; K Pils; R Roller-Wirnsberger; E Beubler; R Gasser; P Mrak; F Hoppichler; P Pietschmann Journal: Z Gerontol Geriatr Date: 2013-07 Impact factor: 1.281